Russian Journal of AllergyRussian Journal of Allergy1810-88302686-682XFarmarus Print Media33310.36691/RJA333Research ArticleAllergen-specific immunotherapy. Analytic review of current international and Russian federal position papersKurbachevaO Mkurbacheva@gmail.comPavlovaK S-GalitzkayaM A-Institute of Immunology15022017141243210032020Copyright © 2017, Pharmarus Print Media2017The article analyses the international position papers devoted to allergen-specific immunotherapy published in recent years. It also describes in details Russian federal guidelines, published in the 2013-2016 years and dedicated to allergen-specific immunotherapy as a method of treatment of IgE-mediated allergic diseases, as well as Russian federal guidelines. Detailed understanding of indications, contraindications, and usage of AIT in various clinical situations are widely discussed.allergen-specific immunotherapyAITinternational consensusallergyimmunotherapyallergovaccineallergic diseasesallergic rhinitisallergic conjunctivitisasthmaanaphylactic reactions to the venom of stinging insectsatopic dermatitisаллерген-специфическая иммунотерапияАСИТМеждународный консенсусаллергияиммунотерапияаллерговакцинааллергические заболеванияаллергический риниталлергический конъюнктивитбронхиальная астмаанафилактические реакции на яд жалящих насекомыхатопический дерматитпоказания и противопоказания к АСИТ[Гущин И.С., Курбачева О.М. Аллергия и аллергенспеци-фическая иммунотерапия. М.: «Фармарус Принт Медиа». 2010, 228 с.][Bousquet J., Lockey R., Malling H.J. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998, v. 53, p. 1-42.][Calderon M.A., Alves B., Jacobson M. et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst. Rev. 2007, v. 24 (1): CD001936.][Jutel M., Agache I., Bonini S. et al. International Consensus On (ICON) Allergy Immunotherapy (AIT). J. Allergy Clin. Immunol. 2015, v. 136 (3), p. 556-568.][Normansell R., Kew K.M., Bridgman A.L. Sublingual immunotherapy for asthma. Cochrane Database Syst. Rev. 2015, v. 28 (8): CD011293.][Radulvic S., Calderon M.A., Wilson D., Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst. Rev. 2010, v. 8 (12): CD002893.][Canonica G.W., Bachert C., Hellings P. et al. Allergen Immunotherapy (AIT): a prototype of Precision Medicine World Allergy Organ J. 2015, v. 10, p. 31.][Jutel M., Agache I., Bonini S. et al. International Consensus On (ICON) Allergy Immunotherapy II: Mechanisms, standardization and pharmacoeconomics. J. Allergy Clin. Immunol. 2016, v. 137, p. 358-368.][Canonica G.W, Baena Cagnani C.E., Bousquet J. et al. Recommendations for standardized clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of the World Allergy Organization (WAO) taskforce. Allergy. 2007, v. 62, p. 317-324.][Pfaar O., Demoly P., Gerth van Wijk R. et al. EAACI. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014, v. 69 (7), p. 854-867.][Rösner-Friese K., Kaul S., Vieths S., Pfaar O. Environmental exposure chambers in allergen immunotherapy trials: current status and clinical validation needs. J. Allergy Clin. Immunol. 2015, v. 135, p. 636-643.][Bauer C.S., Rank M.A. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy. J. Allergy Clin. Immunol. 2014, v. 134, p. 65-765.][Casale T.B., Stokes J.R. Immunotherapy: what lies beyond. J. Allergy Clin. Immunology. 2014, v. 133, p. 612-619.][Von Moos S., Johansen P., Tay F. et al. Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy. J. Allergy Clin. Immunol. 2014, v. 134, p. 965-967.][Tabar A.I., Echechipia S., Garcia B.E. et al. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J. Allergy Clin. Immunol. 2005, v. 116, p. 109-118.][CMS update: Desensitizing vaccines. Br. Med. J. 1986; 293:948.][Temino V.M., Wu P., Konig J., Fahrenholz J.M. Safety of multiple aeroallergen rush immunotherapy using a modified schedule. Allergy Asthma Proc. 2013, v. 34, p. 255-260.][Rieker-Schwienbacher J., Nell M.J., Diamant Z. et al. Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients. Clin. Transl. Allergy. 2013, v. 3, p. 42.][Durham S.R., Walker S.M., Varga E.M. et al. Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. J. Med. 1999, v. 341, p. 468-475.][Des Roches A., Paradis L., Knani J. et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. 1996, v. 51, p. 430-433.][Marogna M., Spadolini I., Massolo A. et al. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J. Allergy Clin. Immunol. 2010, v. 126, p. 969-975.][Calderon M.A., Cox L., Casale T.B. et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J. Allergy Clin. Immunol. 2012, v. 129, p. 929-934.][Cox L.S., Linnemann D.L., Nolte H. et al. Sublingual immunotherapy: a comprehensive review. J. Allergy Clin. Immunol. 2006, v. 117, p. 1021-1035.][Passalacqua G., Baena-Cagnani C.E., Bousquet J. et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J. Allergy Clin. Immunol. 2013, v. 132, p. 93-98.][Cox L., Larenas-Linnemann D., Lockey R.F., Passalacqua G. Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J. Allergy Clin. Immunol. 2010, v. 125, p. 569-574.][Coop C.A., Tankersley M.S. Patient perceptions regarding local reactions from allergen immunotherapy injections. Ann. Allergy Asthma Immunol. 2008, v. 101, p. 96-100.][Kelso J.M. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction. Ann. Allergy Asthma Immunol. 2004, v. 92, p. 225-227.][Tankersley M.S., Butler K.K., Butler W.K., Goetz D.W. Local reactions during allergen immunotherapy do not require dose adjustment. J. Allergy Clin. Immunol. 2000, v. 106, p. 840-843.][Roy S.R., Sigmon J.R., Olivier J. et al. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann. Allergy Asthma Immunol. 2007, v. 99, p. 82-86.][Amin H.S., Liss G.M., Bernstein D.I. Evaluation of near-fatal reactions to allergen immunotherapy injections. J. Allergy Clin. Immunol. 2006, v. 117, p. 169-175.][Schiappoli M., Ridolo E., Senna G. et al. A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. Clin. Exp. Allergy. 2009, v. 39, p. 1569-1574.][Passalacqua G., Guerra L., Compalati E., Canonica G.W The safety of allergen specific sublingual immunotherapy. Curr. Drug. Saf. 2007, v. 2, p. 117-123.][Brozek J.L., Bousquet J., Baena-Cagnani C.E. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J. Allergy Clin. Immunol. 2010, v. 126, p. 466-476.][Bousquet J., Schunemann H.J., Samolinski B. et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J. Allergy Clin. Immunol. 2012, v. 130, p. 1049-1062.][Canonica G.W., Bousquet J., Casale T. et al. Sublingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy. 2009, v. 64, p. 1-59.][Canonica G.W, Cox L., Pawankar R. et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J. 2014, v. 7, p. 6. Российский Аллергологический ^^урнал № 1-2017][Burks A.W., Calderon M.A., Casale T. et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J. Allergy Clin. Immunol. 2013, v. 131, p. 1288-1296.][Malling H.J., Bousquet J. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. Clin. Allergy Immunol. 2008, v. 21, p. 343-358.][Wilson D.R., Lima M.T., Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy. 2005, v. 60, p. 4-12.][Jacobsen L., Niggemann B., Dreborg S. et al. The PAT Investigator Group. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007, v. 62, p. 943-948.][Des Roches A., Paradis L., Menardo J.L., Bouges S., Daures J.P., Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J. Allergy Clin. Immunol. 1997, v. 99, p. 450-453.][Purello-D’Ambrosio F., Gangemi S., Merendino R.A. et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin. Exp. Allergy. 2001, v. 31, p. 1295-1302.][Tahamiler R., Saritzali G., Canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope. 2007, v. 117, p. 965-969.][Kim J.M., Lin S.Y., Suarez-Cuervo C. et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics. 2013, v. 131, p. 1155-1167.][Schiappoli M., Ridolo E., Senna G. et al. A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. Clin. Exp. Allergy. 2009, v. 39, p. 1569-1574.][Agache I., Akdis C., Jutel M., Virchow J.C. Untangling asthma phenotypes and endotypes. Allergy. 2012, v. 67, p. 835-846.][Jutel M., Van de Veen W., Agache I., Azkur K.A. et al. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development. Allergol. Int. 2013, v. 62, p. 425-433.][From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. Available at: http://www.ginasthma.org/. Accessed June 30, 2015.][Mosbech H., Deckelmann R., de Blay F. et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 2014, v. 134, p. 568-575.][Lin S.Y., Erekosima N., Suarez-Cuervo C. et al. Allergen-specific immunotherapy for the treatment of allergic rhinocon-junctivitis and/or asthma: comparative effectiveness review. Comparative Effectiveness Review No. 111. (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-2007-10061-I.) AHRQ Publication No. 13-EHC061-EF. Rockville (MD): Agency for Healthcare Research and Quality. 2013.][Abramson M.J., Puy R.M., Weiner J.M. Injection allergen immunotherapy for asthma. Cochrane Database Syst. Rev. 2010, v. (8): CD001186.][Erekosima N., Suarez-Cuervo C., Ramanathan M. et al. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope. 2014, v. 124, p. 616-627.][Lin S.Y., Erekosima N., Kim J.M. et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA. 2013, v. 309, p. 1278-1288.][De Blay F., Kuna P., Prieto L. et al. SQ HDM SLITtablet (ALK) in treatment of asthma - post hoc results from a randomized trial. Respir. Med. 2014, v. 108, p. 1430-1437.][Marogna M., Braidi C., Bruno M.E. et al. The contribution of sublingual immunotherapy to the achievement of control in birchrelated mild persistent asthma: a real-life randomized trial. Allergol. Immunopathol (Madr). 2013, v. 41, p. 216-224.][Cox L., Nelson H., Lockey R. et al. Allergen immunotherapy: a practice parameter third update. J. Allergy Clin. Immunol. 2011, v. 127, p. 1-55.][Calderon M.A., Cox L., Casale TB. et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J. Allergy Clin. Immunol. 2012, v. 129, p. 929-934.][Calderon M.A., Simons F.E., Malling H.J. et al. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy. 2012, v. 67, p. 302-311.][Stelmach I., Sobocinska A., Majak P. et al. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy. Ann. Allergy Asthma Immunol. 2012, v. 109, p. 274-278.][Passalacqua G., Guerra L., Compalati E., Canonica G.W. The safety of allergen specific sublingual immunotherapy. Curr. Drug. Saf. 2007, v. 2, p. 117-123.][Penagos M., Passalacqua G., Compalati E. et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest. 2008, v. 133, p. 599-609.][Werfel T., Breuer K., Rueff F. et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy. 2006, v. 61, p. 202-205.][Bae J.M., Choi YY, Park C.O. et al. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J. Allergy Clin. Immunol. 2013, v. 132, p. 110-117.][Novak N., Bieber T, Hoffmann M. et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J. Allergy Clin. Immunol. 2012, v. 130, p. 925-931.][Gendelman S.R., Lang D.M. Specific immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system. Ann. Allergy Asthma Immunol. 2013, v. 111, p. 555-561.][Pajno G.B., Caminiti L., Vita D. et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J. Allergy Clin. Immunol. 2007, v. 120, p. 164-170.][Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J. Eur. Acad. Dermatol. Venereol. 2012, v. 26, p. 1176-1193.][Darsow U. Allergen-specific immunotherapy for atopic eczema: updated. Curr. Opin. Allergy Clin. Immunol. 2012, v. 12, p. 665-669.][Schofield A.T. A case of egg poisoning. Lancet. 1908, v. 1, p. 716.][Nurmatov U., Venderbosch I., Devereux G. et al. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst. Rev. 2012, v. 9: CD009014.][Buchanan A.D., Green T.D., Jones S.M. et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J. Allergy Clin. Immunol. 2007, v. 119, p. 199-205.][Keet C.A., Fiischmeyer-Guerreiio P.A., Thyagarajan A. et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J. Allergy Clin. Immunol. 2012, v. 129, p. 448-455.][Zuidmeer-Jongejan L., Fernandez-Rivas M., Poulsen L.K. et al. FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies. Clin. Transl. Allergy. 2012, v. 2, p. 5.][Burks A.W., Jones S.M., Wood R.A. et al. Oral immunotherapy for treatment of egg allergy in children. N. Engl. J. Med. 2012, v. 367, p. 233-243.][Nadeau K.C., Kohli A., Iyengar S. et al. Oral immunotherapy and anti-IgE antibody-adjunctive treatment for food allergy. Immunol. Allergy Clin. North Am. 2012, v. 32, p. 111-133.][Vickery B.P., Scurlock A.M., Kulis M. et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J. Allergy Clin. Immunol. 2014, v. 133, p. 468-475.][Syed A., Garcia M.A., Lyu S.C. et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J. Allergy Clin. Immunol. 2014, v. 133, p. 500-510.][Nowak-Wegrzyn A., Bloom K.A., Sicherer S.H. et al. Tolerance to extensively heated milk in children with cow’s milk allergy. J. Allergy Clin. Immunol. 2008, v. 122, p. 342-347, p. 1-2.][Kim J.S., Nowak-Wegrzyn A., Sicherer S.H. et al. Dietary baked milk accelerates the resolution of cow’s milk allergy in children. J. Allergy Clin. Immunol. 2011, v. 128, p. 125-131.][De Silva D., Geromi M., Panesar S.S. et al. Acute and longterm management of food allergy: systematic review. Allergy. 2014, v. 69, p. 159-167.][Muraro A., Werfel T., Hoffmann-Sommergruber K. et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014, v. 69, p. 1008-1025.]